HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rovere-Querini, P. Articles by Castiglioni, M. T. Search for Related Content PubMed PubMed Citation Articles by Rovere-Querini, P. Articles by Castiglioni, M. T. Related Collections Immunology Medical complications of pregnancy Obstetric complications of pregnancy Pathology

Plasma and Tissue Expression of the Long Pentraxin 3 During Normal Pregnancy and Preeclampsia

From the ¹Clinical Immunology Unit, ²Division of Pathology, ³Division of Gynaecology and Obstetrics, and ⁴Division of Nephrology, H. San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milano, Italy.

OBJECTIVE: Cell death normally occurs during pregnancy and is critical during its common complication, preeclampsia. The long pentraxin 3 (PTX3) gene is generated in tissues that cope with excessive or deregulated cell death and inhibits the cross-presentation of cell-associated antigens. We examined whether PTX3 is expressed during pregnancy and possibly involved in the development of preeclampsia.

METHODS: Women with preeclampsia (n = 30), women with uncomplicated pregnancies (n = 66), age-matched healthy women (n = 50), women who developed acute bacterial infections (n = 20), and women with rheumatoid arthritis (n = 20) were studied. The concentrations of PTX3 were measured in the blood by a sandwich enzyme-linked immunosorbent assay (ELISA) and in placentas by immunohistochemistry. The concentrations of PTX3 and C-reactive protein in the various groups were compared by nonparametric tests (the Mann-Whitney U and the Kruskal-Wallis tests). The odds of developing preeclampsia were assessed using logistic regression.

RESULTS: PTX3 was expressed in amniotic epithelium and chorionic mesoderm, trophoblast terminal villi, and perivascular stroma in placentas from pregnancies of uncomplicated subjects. Circulating levels steadily rose during normal gestation and peaked during labor. Serum levels of PTX3 were strikingly higher in preeclampsia compared with normal control pregnancies (5.08 ± 1.34 and 0.59 ± 0.07 ng/mL, respectively, P < .001). Sites of higher expression in the placentas from preeclamptic patients include infarcts and fibrinoid zones.

CONCLUSION: Defects in the homeostatic response to cell death/remodeling events, revealed by enhanced levels of PTX3, could be implicated in preeclampsia.

LEVEL OF EVIDENCE: II-2

This article has been cited by other articles:

				B. Huppertz Placental Origins of Preeclampsia: Challenging the Current Hypothesis Hypertension, April 1, 2008; 51(4): 970 - 975. [Full Text] [PDF]

				R. M. Popovici, M. S. Krause, J. Jauckus, A. Germeyer, I. S. Brum, C. Garlanda, T. Strowitzki, and M. von Wolff The Long Pentraxin PTX3 in Human Endometrium: Regulation by Steroids and Trophoblast Products Endocrinology, March 1, 2008; 149(3): 1136 - 1143. [Abstract] [Full Text] [PDF]